Suzanne de Bruijn

250 Chapter 5 Table 4. Clinical evaluation of affected individuals Case Class Gender Age of onset (yr) Otoscopic examination Newborn hearing screening Motor development Imaging Audiometric evaluation CT MRI Subject age (yr) PTA (0.5-4kHz) R L SLC014 M0 M PC N 3rd time pass Delayed B EVA 4 >120 55 SLC015 F PS myringosclerosis N NR U EVA R 25 29 66 SLC017 M PC N NA NR B EVA 5 10 59 SLC043 F PC N N NR U EVA L 17 10 95 SLC052 F 33 N NA NR B EVA 33 20 >120 SLC069 F 15 N NA NR B EVA 19 43 42 SLC070 M PC N NA N B EVA 19 43 31 SLC073 M U L: atelectatic middle ear, retracted eardrum NA NR U EVA R 12 11 18 SLC084 F PC N 3rd time pass Delayed B EVA 6 29 38 SLC086 M PC N N Delayed B EVA 6 54 41 SLC039 M0/CEVA F 2-4 N NA NR B EVA 24 46 70 SLC080 F 5 N N N B EVA 6 40 53 SLC002 M1 F U N NA NR B EVA 18 83 76 SLC018 M PC N NA N B EVA* 16 75 101 SLC032 F PC N NA NR B EVA* 59 119 >120 SLC045 F PC N N N B EVA 7 20 69 SLC003 M1/CEVA M 15 N NA NR U EVA R 17 83 -1 SLC012 M PC N NA NR B EVA 17 >120 53 SLC013 F U N NA NR B EVA 22 36 9 SLC031 M PS N 2nd time pass N U EVA L 16 0 68